نتائج البحث - Lori Wood

تنقيح النتائج
  1. 1
    Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal

    Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal حسب Soniya Dulal, Bishnu Dutta Paudel, Prakash Neupane, Aarati Shah, Bibek Acharya, Bishesh Sharma Poudyal, Ramila Shilpakar, Lori Wood

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review

    Evolving landscape of first-line combination therapy in advanced renal cancer: a systematic review حسب Aly‐Khan A. Lalani, Daniel Y.C. Heng, Naveen S. Basappa, Lori Wood, Nayyer Iqbal, Deanna McLeod, Denis Soulières, Christian Kollmannsberger

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Cancer Study Group cooperative study

    Preclinical and clinical activity of sunitinib in patients with cisplatin-refractory or multiply relapsed germ cell tumors: a Canadian Urologic Oncology Group/German Testicular Can... حسب Karin Oechsle, Friedemann Honecker, Tina Cheng, Frank Mayer, Piotr Czaykowski, Eric Winquist, Lori Wood, Martin Fenner, Stephanie Glaesener, J.T. Hartmann, K.N. Chi, Carsten Bokemeyer, Christian Kollmannsberger

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Progression‐free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy

    Progression‐free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy حسب Daniel Y.C. Heng, Wanling Xie, Georg A. Bjarnason, Ulka N. Vaishampayan, Min‐Han Tan, Jennifer J. Knox, Frede Donskov, Lori Wood, Christian Kollmannsberger, Brian I. Rini, Toni K. Choueiri

    منشور في 2010
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer Progressing after First-line Docetaxel: CUOG Trial P-06c

    Randomized Phase II Trial of Custirsen (OGX-011) in Combination with Docetaxel or Mitoxantrone as Second-line Therapy in Patients with Metastatic Castrate-Resistant Prostate Cancer... حسب Fred Saad, Sébastien J. Hotte, Scott North, Bernhard J. Eigl, Kim Chi, Piotr Czaykowski, Lori Wood, Michaël Pollak, Scott Berry, Jean‐Baptiste Lattouf, Som D. Mukherjee, Martin Gleave, Eric Winquist

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805

    Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805 حسب Naomi B. Haas, Judith Manola, Bonnie Ky, Keith T. Flaherty, Robert G. Uzzo, Christopher J. Kane, Michael A.S. Jewett, Lori Wood, Christopher G. Wood, Michael B. Atkins, Janice Dutcher, George Wilding, Robert S. DiPaola

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy

    Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy حسب D.Y.C. Heng, Mary J. MacKenzie, Ulka N. Vaishampayan, Georg A. Bjarnason, Jennifer J. Knox, Min‐Han Tan, Lori Wood, Yingxu Wang, Christian Kollmannsberger, Scott North, Frede Donskov, Brian I. Rini, Toni K. Choueiri

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

    External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study حسب Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, Lauren C. Harshman, Georg A. Bjarnason, Ulka N. Vaishampayan, Mary J. MacKenzie, Lori Wood, Frede Donskov, Min-Han Tan, Sun Young Rha, Neeraj Agarwal, Christian Kollmannsberger, Brian I. Rini, Toni K. Choueiri

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO)

    Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO) حسب Patrícia Moretto, Lori Wood, Urban Emmenegger, Normand Blais, Som D. Mukherjee, Eric Winquist, Eric C. Bélanger, Robert M. MacRae, A. Balogh, Ilias Cagiannos, Wassim Kassouf, Peter C. Black, Joel Gingerich, Scott North, Scott Ernst, Srikala S. Sridhar, M. Neil Reaume, Denis Soulières, Andrea Eisen, Christina M. Canil

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

    Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials حسب D.Y.C. Heng, Toni K. Choueiri, Brian I. Rini, J. Lee, Takeshi Yuasa, Sumanta K. Pal, S. Srinivas, Georg A. Bjarnason, Jennifer J. Knox, Mary J. MacKenzie, Ulka N. Vaishampayan, Min Tan, Sun Young Rha, Frede Donskov, N. Agarwal, Christian Kollmannsberger, Scott North, Lori Wood

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study

    Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study حسب Lauren C. Harshman, Wanling Xie, Georg A. Bjarnason, Jennifer J. Knox, Mary J. MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishampayan, Min-Han Tan, Sun Young Rha, Frede Donskov, Neeraj Agarwal, Christian Kollmannsberger, Scott North, Brian I. Rini, Daniel Y.C. Heng, Toni K. Choueiri

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Canadian consensus guidelines for the management of testicular germ cell cancer

    Canadian consensus guidelines for the management of testicular germ cell cancer حسب Lori Wood, Christian Kollmannsberger, Michael A.S. Jewett, Peter Chung, Sébastien J. Hotte, Martin O’Malley, Joan Sweet, Lynn Anson‐Cartwright, Eric Winquist, Scott North, Scott Tyldesley, Jeremy Sturgeon, Mary Gospodarowicz, Roanne Segal, Tina Cheng, Peter Venner, Malcolm J. Moore, Peter Albers, Robert Huddart, Craig R. Nichols, Padraig Warde

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

    The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients حسب Mhd Yaser Al-Marrawi, Brian I. Rini, Lauren C. Harshman, Georg A. Bjarnason, Lori Wood, Ulka N. Vaishampayan, Mary J. MacKenzie, Jennifer J. Knox, Neeraj Agarwal, Hulayel Alharbi, Christian Kollmannsberger, Min-Han Tan, Sun Young Rha, Frede Donskov, Scott North, Toni K. Choueiri, Daniel Y.C. Heng

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy

    Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy حسب Rana R. McKay, Nils Kroeger, Wanling Xie, Jae‐Lyun Lee, Jennifer J. Knox, Georg A. Bjarnason, Mary J. MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishampayan, Sun Young Rha, Sumanta K. Pal, Frede Donskov, Srinivas K. Tantravahi, Brian I. Rini, Daniel Y.C. Heng, Toni K. Choueiri

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

    Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium حسب Steven Yip, J. Connor Wells, Raphael Brandão Moreira, Alex H.C. Wong, Sandy Srinivas, Benoit Beuselinck, Camillo Porta, Hao‐Wen Sim, D. Scott Ernst, Brian I. Rini, Takeshi Yuasa, Naveen S. Basappa, Ravindran Kanesvaran, Lori Wood, Christina Canil, Anil Kapoor, Simon Fu, Toni K. Choueiri, Daniel Y.C. Heng

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

    First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium حسب Shaan Dudani, Jeffrey Graham, J. Connor Wells, Ziad Bakouny, Sumanta K. Pal, Nazlı Dizman, Frede Donskov, Camillo Porta, Guillermo de Velasco, Aaron R. Hansen, Marco Iafolla, Benoit Beuselinck, Ulka N. Vaishampayan, Lori Wood, Elizabeth Liow, Flora Yan, Takeshi Yuasa, Georg A. Bjarnason, Toni K. Choueiri, Daniel Y.C. Heng

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance Status Patients

    Real-World Efficacy and Toxicity of Ipilimumab and Nivolumab as First-Line Treatment of Metastatic Renal Cell Carcinoma (mRCC) in a Subpopulation of Elderly and Poor Performance St... حسب Noa Shani Shrem, Ana-Alicia Beltran-Bless, Sunita Ghosh, Camilla Tajzler, Lori Wood, C. Kollmannsberger, Naveen S. Basappa, Jeffrey Graham, Nazanin Fallah‐Rad, Daniel Yick Chin Heng, Denis Soulières, Aly‐Khan A. Lalani, Rodney H. Breau, Antonio Finelli, Simon Tanguay, Bimal Bhindi, Georg A. Bjarnason, Frédéric Pouliot, Christina Canil

    منشور في 2025
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

    Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials حسب Chun Loo Gan, Igor Stukalin, Daniel E. Meyers, Shaan Dudani, Heidi A.I. Grosjean, Samantha Dolter, Benjamin W. Ewanchuk, Siddhartha Goutam, Michael Sander, J. Connor Wells, Aliyah Pabani, Tina Cheng, Jose Gerard Monzon, Don Morris, Naveen S. Basappa, Sumanta K. Pal, Lori Wood, Frede Donskov, Toni K. Choueiri, Daniel Y.C. Heng

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria

    Metastatic non–clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consort... حسب Nils Kroeger, Wanling Xie, Jae‐Lyn Lee, Georg A. Bjarnason, Jennifer J. Knox, Mary J. MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishamayan, Sun Young Rha, Sumanta K. Pal, Takeshi Yuasa, Frede Donskov, Neeraj Agarwal, Christian Kollmannsberger, Min‐Han Tan, Scott North, Brian I. Rini, Toni K. Choueiri, Daniel Y.C. Heng

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

    Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium حسب Daniel Y.C. Heng, J. Connor Wells, Brian I. Rini, Benoit Beuselinck, Jae‐Lyun Lee, Jennifer J. Knox, Georg A. Bjarnason, Sumanta K. Pal, Christian Kollmannsberger, Takeshi Yuasa, Sandy Srinivas, Frede Donskov, Aristotelis Bamias, Lori Wood, D. Scott Ernst, Neeraj Agarwal, Ulka N. Vaishampayan, Sun Young Rha, Jenny J. Kim, Toni K. Choueiri

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: